Melasma suprarenale: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 16: Line 16:


{{CMG}}
{{CMG}}
{{Editor Help}}
{{Editor Help}}



Revision as of 14:46, 19 January 2009

Melasma suprarenale

WikiDoc Resources for Melasma suprarenale

Articles

Most recent articles on Melasma suprarenale

Most cited articles on Melasma suprarenale

Review articles on Melasma suprarenale

Articles on Melasma suprarenale in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Melasma suprarenale

Images of Melasma suprarenale

Photos of Melasma suprarenale

Podcasts & MP3s on Melasma suprarenale

Videos on Melasma suprarenale

Evidence Based Medicine

Cochrane Collaboration on Melasma suprarenale

Bandolier on Melasma suprarenale

TRIP on Melasma suprarenale

Clinical Trials

Ongoing Trials on Melasma suprarenale at Clinical Trials.gov

Trial results on Melasma suprarenale

Clinical Trials on Melasma suprarenale at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Melasma suprarenale

NICE Guidance on Melasma suprarenale

NHS PRODIGY Guidance

FDA on Melasma suprarenale

CDC on Melasma suprarenale

Books

Books on Melasma suprarenale

News

Melasma suprarenale in the news

Be alerted to news on Melasma suprarenale

News trends on Melasma suprarenale

Commentary

Blogs on Melasma suprarenale

Definitions

Definitions of Melasma suprarenale

Patient Resources / Community

Patient resources on Melasma suprarenale

Discussion groups on Melasma suprarenale

Patient Handouts on Melasma suprarenale

Directions to Hospitals Treating Melasma suprarenale

Risk calculators and risk factors for Melasma suprarenale

Healthcare Provider Resources

Symptoms of Melasma suprarenale

Causes & Risk Factors for Melasma suprarenale

Diagnostic studies for Melasma suprarenale

Treatment of Melasma suprarenale

Continuing Medical Education (CME)

CME Programs on Melasma suprarenale

International

Melasma suprarenale en Espanol

Melasma suprarenale en Francais

Business

Melasma suprarenale in the Marketplace

Patents on Melasma suprarenale

Experimental / Informatics

List of terms related to Melasma suprarenale

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

OVerview

Melasma suprarenale is Latin, meaning literally "darkening, (of) above the kidneys" which signifies that it is caused by disease in the adrenal glands (also known as "suprarenal glands", and originally known as the "supra-renal capsules").

Signs and symptoms

The condition most commonly causing the darkening of skin is known as Addison's disease. The darkening may be brown or reddish, typically appearing in the creases of the palms, pressure areas of the body and the mouth. In Addison's disease it is caused by excess production of adrenocorticotropic hormone (ACTH), which simultaneously releases a compound called melanocyte stimulating hormone (MSH).

Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs

Template:SIB


Template:WikiDoc Sources